Navigation Links
Donation for new Center for Pharmaceutical Nanotechnology and Nanotoxicology
Date:12/18/2008

Prof. Moein Moghimi (Professor of Biopharmacy and Nanomedicine, Department of Pharmaceutics and Analytical chemistry) and colleagues have received 28 million DKK (approximately 3.75 million Euros) from the Danish Council for Strategic Research (DSF) to set The Centre for Pharmaceutical Nanotechnology and Nanotoxicology (CPNN) at the Faculty of Pharmaceutical Sciences starting April 2009.

Prof. Moghimi will act as the Director of the Centre and Prof. Thomas Bjrnholm (Head of the NanoScience Centre) will be the Chairman of the Steering Committee.

The development of a wide spectrum of promising nanoscale materials, either in their own right or as a component of multifunctional platforms, is beginning to have a paradigm-shifting impact in medicine; they are changing the foundations of disease diagnosis, monitoring and treatment, and turning molecular discoveries into benefits for patients. Research into delivery and targeting of pharmaceutical, therapeutic, and diagnostic agents via intravenous and interstitial routes of administration with particulate drug carriers and nanoconstructs is at the forefront of projects in nanomedicine, but the biological performance of such delivery systems still requires optimization.

The principal investigator Prof. Moghimi said "the future of particulate and polymeric nanomedicines will depend on rational design of nanotechnology materials and tools based around a detailed and thorough molecular understanding of biological processes, rather than forcing applications for some materials currently in vogue". Therefore, the prime research focus of the Centre is to unravel the molecular basis of nanomaterial performance and toxicity through "structure-activity" assessments at membrane organelle, cellular and animal level in combination with and by improving/optimizing the performance of the state-of-the-art bio-nanotechnology techniques. This integrated and multidisciplinary approach is expected to improve
'/>"/>

Contact: Professor Seyed Moein Moghimi
momo@farma.ku.dk
453-533-6528
University of Copenhagen
Source:Eurekalert

Page: 1 2

Related biology news :

1. Trustee makes donation to start new solar energy research center at Rensselaer
2. Georgia Tech/Emory Center to study origin of life
3. Woods Hole Research Center to lead undergraduate initiative in the Siberian Arctic
4. $10 million gift to support cutting-edge epigenome center at USC
5. 3 Columbia University Medical Center faculty elected to Institute of Medicine
6. NHGRI funds new Centers for Excellence in Ethical, Legal and Social Implications Research
7. NYUs Center for Genomics & Systems Biology receives $4.4 million NSF grant
8. Monsanto expands sponsorship for Peking-Yale Joint Agrobiotechnology Center
9. Woods Hole Research Center debuts new image mosaic that will strengthen global forest monitoring
10. DFG to establish 10 new collaborative research centers
11. Ireland Cancer Center researchers advance stem cell gene therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... Society for Bone and Mineral Research awarded Michael F. ... (BUSM), with the 2014 Louis V. Avioli Award. Holick, ... is internationally known for revolutionizing the understanding of vitamin ... The award honors a member of the American Society ... to bone and mineral basic research. It is named ...
(Date:7/11/2014)... . X-ray ... of X-rays through a specimen instead of attenuation resulting ... often of much higher quality than those based on ... Pfeiffer are particularly interested in developing new approaches for ... imaging. One main goal is to make this method ...
(Date:7/11/2014)... the National Institute of Standards and Technology (NIST) ... more effectively, they often prove that necessity is ... case recently for M. Lorna De Leoz and ... specialization of glycomics. Glycomics is the study of ... are attached to proteins and lipids and influence ...
Breaking Biology News(10 mins):BUSM's Michael F. Holick receives American Society for Bone and Mineral Research award 2New simple setup for X-ray phase contrast 2
... a future when man and machine would become one. ... futuristic "vision" of bionics a reality. Prof. Yael ... has foundational research that may give sight to blind ... growth. Successful so far in animal models, this research ...
... Calif., March 19, 2010Under a changing climate, patterns ... how will forest diseases respond? A summary of ... available on the Internet at http://www.fs.fed.us/psw/topics/insect_disease/ . ... titled "Review of Literature on Climate Change and ...
... big jobs in our environment, to go dormant not only ... also play a key role in promoting biodiversity and ecosystem ... Proceedings of National Academy of Sciences , Michigan State ... a mathematical model and molecular tools to study how dormancy ...
Cached Biology News:Seeing a bionic eye on medicine's horizon 2How will tree diseases react to climate change? 2Dormant microbes promote diversity, serve environment 2
(Date:7/10/2014)... OAKS, Calif., July 10, 2014   Ceres, Inc ... and seed company, announced today financial results for the ... update on its business. Ceres reported that ... in product performance this growing season in Brazil, which ... affected the company,s sorghum evaluation areas for part of ...
(Date:7/10/2014)... 2014 Using microscopic polymer light resonators that ... at MIT,s Quantum Photonics Laboratory have developed new ... parts-per-billion range. Optical sensors are ideal for detecting ... ratio, compact, lightweight nature, and immunity to electromagnetic ... been developed before, the MIT team conceived an ...
(Date:7/10/2014)... fractional quantum Hall effect in bilayer graphene and shown ... by an electric field. , The fractional quantum ... thin sheets are exposed to large magnetic fields, is ... individual electrons behave as a single system. However, while ... many details of this collective behavior remain not well ...
(Date:7/10/2014)... out for crude 3-D glasses, polarized glasses, and ... basic devices, used to trick the brain into ... rendered obsolete with the introduction of new holography ... TAU doctoral students Yuval Yifat, Michal Eitan, and ... on nanoantennas that could be used for security ...
Breaking Biology Technology:Ceres Announces Fiscal Third Quarter 2014 Financial Results 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 3Ceres Announces Fiscal Third Quarter 2014 Financial Results 4Ceres Announces Fiscal Third Quarter 2014 Financial Results 5Ceres Announces Fiscal Third Quarter 2014 Financial Results 6Ceres Announces Fiscal Third Quarter 2014 Financial Results 7Ceres Announces Fiscal Third Quarter 2014 Financial Results 8Ceres Announces Fiscal Third Quarter 2014 Financial Results 9Swell new sensors 2Columbia researchers observe tunable quantum behavior in bilayer graphene 2Columbia researchers observe tunable quantum behavior in bilayer graphene 3Projecting a 3-dimensional future 2Projecting a 3-dimensional future 3
... , , , BALTIMORE, ... (OTC Bulletin Board: CSBR), a company engaged in the development ... the value of oncology drugs, has established yet another agreement ... novel oncology therapeutic in Champions, Biomerk Tumorgraft(TM) platform. , ...
... , , ROCKVILLE, Md., ... today favorable results from a Phase II human clinical trial of ... vaccine was well tolerated and induced robust immune responses against all ... support the planned study in elderly adults scheduled for the fourth ...
... COPENHAGEN and OSLO, September 1 Affitech ... announced that it,has appointed two experienced biotech executives ... CEO of Celldex Therapeutics Inc., has today,assumed overall ... Dr Alexander Duncan, previously SVP Biopharmaceuticals for Astra,Zeneca ...
Cached Biology Technology:Champions Biotechnology to Deploy its Technology to Guide Development of Oncology Therapeutic for Global Biotech Leader 2Champions Biotechnology to Deploy its Technology to Guide Development of Oncology Therapeutic for Global Biotech Leader 3NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine Candidate 2NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine Candidate 3NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine Candidate 4NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine Candidate 5Affitech Appoints Dr Robert Burns as CEO and Dr Alexander Duncan as SVP Research & Development 2Affitech Appoints Dr Robert Burns as CEO and Dr Alexander Duncan as SVP Research & Development 3
... standard fixed-angle microcentrifuge rotor at RCF ... tube filters consist of a membrane-containing ... They filter by centrifugation for bacteria ... removal of cells from media and ...
These Costar 96-well, flat-bottom polystyrene EIA plates are used for EIAs, ELISAs, and other protein binding assays. Supplied as box of 100 (20 packages; 5 plates per package)....
... System provides high-throughput, quantitative gene expression analysis ... patented priming strategy overcomes the biases that ... a few genes at a time. ... and more samples per run, removing bottlenecks ...
... provides a convenient method to probe conformational changes ... substrates. Thus, the kit may be used to ... as transport substrates for MDR1. Because UIC2 binding ... substrates, the MDR1 Shift Assay can be utilized ...
Biology Products: